GWAS have demonstrated robust links between NAFLD progression and variations in certain genes, including PNPLA3, TM6SF2, MBOAT7, GCKR, and HSD17B13 [53]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.